Identifying novel gene dysregulation associated with opioid overdose death: A meta-analysis of differential gene expression in human prefrontal cortex

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work is supported by the National Institute on Drug Abuse R01 DA043980 (PIs: Scacheri, Johnson, Ackbarian), R21 DA050160 (Pls: Montalvo-Ortiz, JL), R01 DA051390 (Pls: Logan, RW), R01 DA044859 (PI Walss-Bass), and P50 DA05471 (PIs: Eric Johnson)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Corradin O, Sallari R, Hoang AT, Kassim BS, Ben Hutta G, Cuoto L, et al. Convergence of case specific epigenetic alterations identify a confluence of genetic vulnerabilities tied to opioid overdose. Mol Psychiatry. 2022 Apr;27(4):215870. Mendez EF, Wei H, Hu R, Stertz L, Fries GR, Wu X, et al. Angiogenic Gene Networks are Dysregulated in Opioid Use Disorder: Evidence from MultiOmics and Imaging of Postmortem Human Brain. Mol Psychiatry. 2021 Dec;26(12):780312. Seney ML, Kim SM, Glausier JR, Hildebrand MA, Xue X, Zong W, et al. Transcriptional Alterations in Dorsolateral Prefrontal Cortex and Nucleus Accumbens Implicate Neuroinflammation and Synaptic Remodeling in Opioid Use Disorder. Biol Psychiatry. 2021 Oct 15;90(8):55062. Sosnowski DW, Jaffe AE, Tao R, Deep Soboslay A, Shu C, Sabunciyan S, et al. Differential expression of NPAS4 in the dorsolateral prefrontal cortex following opioid overdose. Drug Alcohol Depend Rep. 2022 Jun 1;3:100040.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes